Sarcoma trials in China

In China 106 Also abroad 605

106 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
Where
Beijing, Changchun, Chengdu, Foshan, Guangzhou, Hangzhou, HangzhouZhejiang, Hefei, Jinan, Nanchang, Nanjing, Shenzhen, Suzhou, Taizhou, Tianjin
Age
18 years and over
People
400 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07541170 · EU 2025-524263-21-01
Phase 1Enrolling by invitation
Evaluation of the I-phase Clinical Trial of 177Lu-HX02 Injection in Patients With Advanced Malignant Solid Tumors
Where
Wuhan
Age
18 years to 75 years
People
12
Run by
Hexin (Suzhou) Pharmaceutical Technology Co., Ltd
See details and how to joinNCT07920822
Phase 2Taking people
A Multicenter Phase II Clinical Trial Evaluating 68Ga-HX01 Injection for PET/CT Imaging
Where
Wuhan
Age
18 years and over
People
60
Run by
Hexin (Suzhou) Pharmaceutical Technology Co., Ltd
See details and how to joinNCT07920835
Phase 2Taking people
Zemetostat With Anlotinib in Patients With Recurrent/Metastatic Head and Neck Soft Tissue Sarcoma
Where
Shanghai
Age
18 years to 75 years
People
34
Run by
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT07917949
Phase 2Taking people
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Where
Beijing, Changsha, Hangzhou, Shanghai
Age
18 years and over
People
111 worldwide
Run by
Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00
No phaseTaking people
Retroperitoneal Tumor Registry
Where
Changchun
People
200
Run by
The First Hospital of Jilin University
See details and how to joinNCT07915895
Phase 1/2Not yet taking people in China
Combination Immunotherapy Targeting Sarcomas
Where
Shenzhen
Age
1 year to 75 years
People
20
Run by
Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT04433221
Phase 1/2Not yet taking people in China
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
Where
Shenzhen
Age
1 year to 75 years
People
20
Run by
Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT03356782
No phaseNot yet taking people in China
CTEPH Differential Diagnosis Assisted by Enhanced Large Language Model Support
Where
Beijing
Age
18 years and over
People
60
Run by
China-Japan Friendship Hospital
See details and how to joinNCT07902011
Phase 1/2Taking people
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Where
Beijing, Hangzhou, Wuhan, Xi’an, Zhengzhou
Age
18 years and over
People
430 worldwide
Run by
Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00
Phase 3Taking people
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jiamusi, Jinan, Kunming, Linhai, Linyi, Nanchang, Nanjing, Neijiang, Shanghai, Suzhou, Taiyuan, Ürümqi, Wenzhou, Wuhan, Wuxi, Xiamen, Xi'an, Xian, Zhengzhou
Age
18 years and over
People
348 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00
Phase 1Taking people
A Phase I Study of XS-02 Capsules in Patients With Advanced Solid Tumors
Where
Beijing
Age
18 years to 75 years
People
96
Run by
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
See details and how to joinNCT06531486
Early phase 1Taking people
Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma
Where
Beijing
Age
6 years and over
People
5
Run by
Xinxin Zhang
See details and how to joinNCT06932861
Phase 1Taking people
Preliminary Clinical Study of Entinostat in Children With Malignant Soft Tissue Sarcoma Harboring PAX-family Gene Abnormalities
Where
Beijing
Age
1 year to 18 years
People
16
Run by
Beijing Tongren Hospital
See details and how to joinNCT07888114
No phaseTaking people
Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma
Where
Jinan
Age
18 years to 70 years
People
106
Run by
Shandong Cancer Hospital and Institute
See details and how to joinNCT06980259
No phaseEnrolling by invitation
Radiomics-Based Non-Invasive MRI Differentiation of Uterine Sarcomas and Fibroids
Where
Wuhan
Age
18 years and over
People
520
Run by
Tongji Hospital
See details and how to joinNCT07129005
Phase 1Taking people
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Where
Guangzhou, Shanghai, Wuhan
Age
18 years and over
People
405 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06884618 · EU 2024-519622-20-00
Phase 2Not yet taking people in China
Utidelone Capsules Combined With Doxorubicin for Advanced Soft Tissue Sarcoma
Where
Chengdu
Age
18 years to 70 years
People
49
Run by
Beijing Biostar Pharmaceuticals Co., Ltd.
See details and how to joinNCT07842276
Phase 1Taking people
A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors
Where
Beijing, Changsha, Hangzhou
Age
18 years to 75 years
People
110
Run by
Hangzhou DAC Biotechnology Co., Ltd.
See details and how to joinNCT06926283
Phase 2Not yet taking people in China
SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripalimab as Neoadjuvant Therapy for Localized High-Risk Undifferentiated Pleomorphic Sarcoma
Where
Tianjin
Age
18 years to 75 years
People
39
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07817095
Early phase 1Taking people
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
Where
Wuxi
Age
18 years to 75 years
People
10
Run by
FindCure Biosciences (ZhongShan) Co., Ltd.
See details and how to joinNCT07459283
Phase 2Taking people
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Where
Chengdu, Nanchang, Nanjing, Shanghai
Age
18 years and over
People
140 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07252739 · EU 2025-521939-36-00
Early phase 1Taking people
68Ga-B7-H3 Nanobody ImmunoPET in Osteosarcoma
Where
Beijing
Age
10 years to 80 years
People
16
Run by
Peking University First Hospital
See details and how to joinNCT07774533
No phaseTaking people
Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma
Where
Beijing
Age
10 years to 60 years
People
100
Run by
Peking University People's Hospital
See details and how to joinNCT07725783
Phase 1Taking people
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
Where
Beijing, Shanghai
Age
18 years and over
People
180 worldwide
Run by
Zai Lab (Shanghai) Co., Ltd.
See details and how to joinNCT07374848